Gallbladder Cancer Foundation and Citizen Health Expand Partnership to Offer Ari AI Assistant to Gallbladder Cancer Community

On July 24, 2026, the Gallbladder Cancer Foundation and Citizen Health announced an expanded partnership to make Ari, an AI assistant, available to the gallbladder cancer community. The organizations describe Ari as helping patients consolidate medical records, understand complex pathology and biomarker results, track treatments and side effects, prepare second-opinion summaries, draft insurance appeals, and flag clinical trials to discuss with a doctor. Ari is available free to the gallbladder cancer community, with optional premium tiers. The organizations said Ari asks for permission before acting on a patient's behalf and does not share information without the patient's consent.

GBCF partnership expansion

• ▪The Gallbladder Cancer Foundation and Citizen Health had worked together for approximately one and a half years prior to their July 24, 2026 announcement.
• ▪The Gallbladder Cancer Foundation was founded in 2024 by Sanjeev Kumar as a 501(c)(3) public charity.
• ▪The Gallbladder Cancer Foundation and Citizen Health announced an expansion of their partnership on July 24, 2026, to deploy the AI assistant Ari.

Rare disease support gap

• ▪Patients with rare diseases like gallbladder cancer often lack the tools, guidance, and support systems available to those with more common cancers.
• ▪Citizen Health, headquartered in San Francisco, California, focuses on building healthcare solutions starting with rare diseases.

Ari AI assistant capabilities

• ▪The AI assistant Ari prepares summaries for second opinions, drafts insurance appeals, and flags relevant clinical trials.
• ▪The AI assistant Ari gathers medical records from multiple providers into a single location controlled by the patient.
• ▪The AI assistant Ari translates complex pathology and biomarker results into plain language and tracks treatments and side effects.

Patient data control

• ▪The Gallbladder Cancer Foundation and Citizen Health said Ari asks for permission before acting on a patient's behalf and does not share information without the patient's consent.On July 24, 2026, the Gallbladder Cancer Foundation and Citizen Health announce an expanded partnership to deploy Ari, an AI assistant, to gallbladder cancer patients. Because gallbladder cancer is a rare, aggressive disease, patients face fragmented care and a lack of support resources. Ari addresses these challenges by consolidating medical records, translating complex pathology reports, and identifying clinical trials, all while keeping patient data private and free of charge.
• ▪The AI assistant Ari is free for the gallbladder cancer community, with options to upgrade to premium tiers.

Gallbladder cancer care challenges

• ▪Gallbladder cancer care is often fragmented across multiple surgeons, oncologists, and imaging centers.
• ▪Gallbladder cancer is a rare and aggressive disease that requires rapid decision-making based on dense pathology and molecular reports.

1 source